Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy... Show more
a manufacturer of fluid handling and industrial positioning products
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PTA | 19.07 | 0.11 | +0.58% |
| Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund | |||
| XV | 24.68 | 0.09 | +0.37% |
| Simplify Target 15 Distribution ETF | |||
| TPLS | 24.98 | N/A | N/A |
| Thornburg Core Plus Bond ETF | |||
| XTWO | 48.85 | -0.03 | -0.05% |
| BondBloxx Bloomberg Two YrTrgDurUSTrsETF | |||
| PJIO | 60.70 | -0.20 | -0.32% |
| PGIM Jennison International Opps ETF | |||
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | -0.85% | ||
| CNMD - ENOV | 58% Loosely correlated | +0.58% | ||
| FELE - ENOV | 56% Loosely correlated | -1.30% | ||
| DOV - ENOV | 55% Loosely correlated | -2.12% | ||
| PH - ENOV | 53% Loosely correlated | -0.25% | ||
| ITT - ENOV | 52% Loosely correlated | -0.66% | ||
More | ||||
| Ticker / NAME | Correlation To ENOV | 1D Price Change % |
|---|---|---|
| ENOV | 100% | -0.85% |
| Health Services category (245 stocks) | 5% Poorly correlated | +0.15% |
| Medical/Nursing Services category (139 stocks) | 4% Poorly correlated | -0.28% |
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ENOV declined for three days, in of 343 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
ENOV broke above its upper Bollinger Band on July 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ENOV entered a downward trend on July 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on July 02, 2026. You may want to consider a long position or call options on ENOV as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ENOV just turned positive on July 02, 2026. Looking at past instances where ENOV's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
ENOV moved above its 50-day moving average on July 06, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ENOV crossed bullishly above the 50-day moving average on July 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.046) is normal, around the industry mean (10.868). P/E Ratio (0.000) is within average values for comparable stocks, (64.904). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.960). ENOV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.674) is also within normal values, averaging (24.894).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.